
Joyce Hesselberth & Dave Plunkert’s SPUR Design has just launched a terrific shape-finding and counting app for kids, available on iTunes for $1.99. PrestoBingo Shapes started with a simple idea: the world is full of shapes. (more)
Spend the afternoon of Sunday, January 8th with the artwork of Joyce Hesselberth, Susan Detwiler and Ann Feild Didyk at the Hoffberger Gallery. Originals and limited edition prints available. (more)
Joyce Hesselberth created this illustration for an article in American Lawyer's January issue about the growing percentage of women being made partners in law firms. A 30% average may not seem like much, but it's a big improvement from a couple decades ago. (more)
Today’s New York Times, Science Times section features plenty of quality work by ispotters. Ellen Weinstein starts off by illustrating the dire cost of drug scarcity: (more)
Joyce Hesselberth has been working on a huge project for McGraw-Hill and is thrilled to be able to show the first part of it. The assignment consists of three children's books, plus teachers' guides to accompany each book. The total number of illustrations weighs in at a hefty 156 pages! (more)
The New York Times Tuesday Science Times section was full of great work by members of theispot.com. Viktor Koen illustrates the bitter fruits of envy: (more)
Joyce Hesselberth was recently commissioned by The Chronicle Review to illustrate a story titled, "Starting Over, with a Bad Attitude." (more)
Ispotters were the go-to group of artists again this week for the New York Times Health & Science section. Joyce Hesselberth illustrated an article about optimum drug storage temperatures for maintaining product integrity. (FYI, anything from 58 to 86 degrees is fine.) (more)
Joyce Hesselberth focused on the idea of growing an art community for the image on this Gunpowder River Artfest poster. This year's illustration is being printed on t-shirts, posters, banners and more. (more)
Joyce Hesselberth’s illustration is for a story on how transplant patients are coping with side effects. A new anti-rejection drug appears to offer positive results and researchers at Baylor University Medical Center in Dallas are part of a study to evaluate the medication. (more)